{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T10:22:40Z","timestamp":1785320560073,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s00115-022-01302-5","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T09:04:37Z","timestamp":1653469477000},"page":"629-642","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Die optische Koh\u00e4renztomographie in der Differenzialdiagnostik wichtiger neuroophthalmologischer Krankheitsbilder","Optical coherence tomography in the differential diagnostics of important neuro-ophthalmological disease patterns"],"prefix":"10.1007","volume":"93","author":[{"given":"Maximilian","family":"Schultheiss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Wenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin S.","family":"Spitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Poli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Wilhelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Tonagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Kelbsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,25]]},"reference":[{"key":"1302_CR1","doi-asserted-by":"crossref","unstructured":"DOG, RG, BVA. Leitlinie von DOG, RG und BVA: Retinale arterielle Verschl\u00fcsse (RAV): Stand 11\/2016 [Guidelines from the DOG, RG and BVA: retinal artery occlusion: 11\/2016 status]. Ophthalmologe. 2017 Feb;114(2):120\u201331.","DOI":"10.1007\/s00347-016-0435-1"},{"issue":"Suppl 3","key":"1302_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00393-020-00893-1","volume":"79","author":"JH Schirmer","year":"2020","unstructured":"Schirmer\u00a0JH, Aries\u00a0PM, Balzer\u00a0K, Berlit\u00a0P, Bley\u00a0TA, Buttgereit\u00a0F et al (2020) S2k guidelines: management of large-vessel vasculitis. Z\u00a0Rheumatol 79(Suppl 3):67\u201395","journal-title":"Z Rheumatol"},{"key":"1302_CR3","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s00347-021-01468-4","volume":"118","author":"M Schultheiss","year":"2021","unstructured":"Schultheiss\u00a0M, Poli\u00a0S, Spitzer\u00a0MS (2021) Acute central retinal artery occlusion. Ophthalmologe 118:1091\u20131092","journal-title":"Ophthalmologe"},{"issue":"3","key":"1302_CR4","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1055\/a-1653-1426","volume":"239","author":"M Schulthei\u00df","year":"2022","unstructured":"Schulthei\u00df M, Steinhorst NA, Dippel S, Spitzer MS, Poli S, Feltgen N (2022) Diagnosing central retinal artery occlusion (CRAO) without fundus examination. Klin Monbl Augenheilkd 239(3):288\u2013292. https:\/\/doi.org\/10.1055\/a-1653-1426","journal-title":"Klin Monbl Augenheilkd"},{"key":"1302_CR5","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.119.028743","author":"MB Grory","year":"2020","unstructured":"Grory MB, Nackenoff A, Poli S, Spitzer MS, Nedelmann M, Guillon B et al (2020) Intravenous fibrinolysis for central retinal artery occlusion: a cohort study and updated patient-level meta-analysis. Stroke. https:\/\/doi.org\/10.1161\/STROKEAHA.119.028743","journal-title":"Stroke"},{"key":"1302_CR6","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/01.iae.0000238095.97104.9b","volume":"27","author":"SS Hayreh","year":"2007","unstructured":"Hayreh\u00a0SS, Zimmerman\u00a0MB (2007) Fundus changes in central retinal artery occlusion. Retina 27:276\u2013289","journal-title":"Retina"},{"issue":"11","key":"1302_CR7","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s00347-021-01495-1","volume":"118","author":"DA Wenzel","year":"2021","unstructured":"Wenzel\u00a0DA, Feltgen\u00a0N, Steinhorst\u00a0NA, Poli\u00a0S, Spitzer\u00a0MS, Schultheiss\u00a0M (2021) Acute diagnostics of central retinal artery occlusion and biomarkers of ischemia: Diagnostics with consequences? Ophthalmologe 118(11):1099\u20131106","journal-title":"Ophthalmologe"},{"issue":"6","key":"1302_CR8","doi-asserted-by":"publisher","first-page":"e680","DOI":"10.1111\/aos.14375","volume":"98","author":"GA Ochakovski","year":"2020","unstructured":"Ochakovski\u00a0GA, Wenzel\u00a0DA, Spitzer\u00a0MS, Poli\u00a0S, H\u00e4rtig\u00a0F, Fischer\u00a0MD et\u00a0al (2020) Retinal oedema in central retinal artery occlusion develops as a\u00a0function of time. Acta Ophthalmol 98(6):e680\u2013e684","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"1302_CR9","doi-asserted-by":"publisher","first-page":"e247","DOI":"10.1111\/aos.14563","volume":"99","author":"DA Wenzel","year":"2021","unstructured":"Wenzel\u00a0DA, Kromer\u00a0R, Poli\u00a0S, Steinhorst\u00a0NA, Casagrande\u00a0MK, Spitzer\u00a0MS et al (2021) Optical coherence tomography-based determination of ischaemia onset\u2014the temporal dynamics of retinal thickness increase in acute central retinal artery occlusion. Acta Ophthalmol 99(2):e247\u2013e252","journal-title":"Acta Ophthalmol"},{"key":"1302_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5527292","author":"M Casagrande","year":"2021","unstructured":"Casagrande M, Kromer R, Wenzel DA, Poli S, Spitzer MS, Druchkiv V et al (2021) Determination of Ischemia onset based on automatically generated spectralis SD-OCT values in acute central retinal artery occlusion. J\u00a0Ophthalmol. https:\/\/doi.org\/10.1155\/2021\/5527292","journal-title":"Ophthalmol"},{"key":"1302_CR11","first-page":"1","volume":"5","author":"H Chen","year":"2015","unstructured":"Chen\u00a0H, Chen\u00a0X, Qiu\u00a0Z, Xiang\u00a0D, Chen\u00a0W, Shi\u00a0F et\u00a0al (2015) Quantitative analysis of retinal layers\u2019 optical intensities on 3D optical coherence tomography for central retinal artery occlusion. Sci Rep 5:1\u20136","journal-title":"Sci Rep"},{"issue":"10","key":"1302_CR12","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1097\/IAE.0000000000001017","volume":"36","author":"H Chen","year":"2016","unstructured":"Chen\u00a0H, Xia\u00a0H, Qiu\u00a0Z, Chen\u00a0W, Chen\u00a0X (2016) Correlation of optical intensity on optical coherence tomography and visual outcome in central retinal artery occlusion. Retina 36(10):1964\u20131970","journal-title":"Retina"},{"key":"1302_CR13","volume-title":"Hyperreflektivit\u00e4t der inneren Netzhautschichten als Biomarker des akuten Zentralarterienverschlusses","author":"DA Wenzel","year":"2021","unstructured":"Wenzel\u00a0DA, Grohmann\u00a0C, Poli\u00a0S, Bartz-Schmidt\u00a0KU, Spitzer\u00a0M, Schultheiss\u00a0M (2021) Hyperreflektivit\u00e4t der inneren Netzhautschichten als Biomarker des akuten Zentralarterienverschlusses. Postervortrag, Kongress der Deutschen Ophthalmologischen Gesellschaft (DOG)."},{"issue":"10","key":"1302_CR14","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1097\/IAE.0b013e3182899205","volume":"33","author":"YK Chu","year":"2013","unstructured":"Chu\u00a0YK, Hong\u00a0YT, Byeon\u00a0SH, Kwon\u00a0OW (2013) In vivo detection of acute ischemic damages in retinal arterial occlusion with optical coherence tomography: A \u201cprominent middle limiting membrane sign.\u201d. Retina 33(10):2110\u20132117","journal-title":"Retina"},{"issue":"10","key":"1302_CR15","first-page":"2","volume":"18","author":"M Schnieder","year":"2021","unstructured":"Schnieder\u00a0M, Fischer-wedi\u00a0CV, Bemme\u00a0S, Kortleben\u00a0M, Feltgen\u00a0N, Liman\u00a0J (2021) The retrobulbar spot sign and prominent middle limiting membrane as prognostic markers in non-arteritic retinal artery occlusion. J\u00a0Clin Med 18(10):2","journal-title":"J Clin Med"},{"issue":"11","key":"1302_CR16","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1055\/a-0942-7750","volume":"236","author":"F Tonagel","year":"2019","unstructured":"Tonagel\u00a0F, Kernstock\u00a0C, Wilhelm\u00a0H, Kelbsch\u00a0C (2019) Optic disc drusen. Klin Monbl Augenheilkd 236(11):1292\u20131297","journal-title":"Klin Monbl Augenheilkd"},{"issue":"7","key":"1302_CR17","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/aos.13748","volume":"96","author":"S Hamann","year":"2018","unstructured":"Hamann\u00a0S, Malmqvist\u00a0L, Costello\u00a0F (2018) Optic disc drusen: understanding an old problem from a\u00a0new perspective. Acta Ophthalmol 96(7):673\u2013684","journal-title":"Acta Ophthalmol"},{"issue":"1\u20132","key":"1302_CR18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/s0304-3959(02)00348-2","volume":"102","author":"M Lant\u00e9ri-Minet","year":"2003","unstructured":"Lant\u00e9ri-Minet\u00a0M, Auray\u00a0J\u2011P, El Hasnaoui\u00a0A, Dartigues\u00a0J\u2011F, Duru\u00a0G, Henry\u00a0P et al (2003) Prevalence and description of chronic daily headache in the general population in France. Pain 102(1\u20132):143\u2013149","journal-title":"Pain"},{"issue":"3","key":"1302_CR19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/WNO.0000000000000585","volume":"38","author":"L Malmqvist","year":"2018","unstructured":"Malmqvist\u00a0L, Bursztyn\u00a0L, Costello\u00a0F, Digre\u00a0K, Fraser\u00a0JA, Fraser\u00a0C et\u00a0al (2018) The optic disc drusen studies consortium recommendations for diagnosis of optic disc drusen using optical coherence tomography. J\u00a0Neuroophthalmol 38(3):299\u2013307","journal-title":"J Neuroophthalmol"},{"issue":"1","key":"1302_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/01658107.2020.1810286","volume":"45","author":"F Costello","year":"2021","unstructured":"Costello\u00a0F, Rothenbuehler\u00a0SP, Sibony\u00a0PA, Hamann\u00a0S (2021) Diagnosing optic disc drusen in the modern imaging era: a practical approach. Neuroophthalmology 45(1):1\u201316","journal-title":"Neuroophthalmology"},{"issue":"1","key":"1302_CR21","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ajo.2014.03.008","volume":"158","author":"MA Fard","year":"2014","unstructured":"Fard\u00a0MA, Fakhree\u00a0S, Abdi\u00a0P, Hassanpoor\u00a0N, Subramanian\u00a0PS (2014) Quantification of peripapillary total retinal volume in pseudopapilledema and mild papilledema using spectral-domain optical coherence tomography. Am J Ophthalmol 158(1):136\u2013143","journal-title":"Am J Ophthalmol"},{"key":"1302_CR22","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1097\/WNO.0000000000000674","volume":"38","author":"L Malmqvist","year":"2018","unstructured":"Malmqvist\u00a0L, Bursztyn\u00a0L, Costello\u00a0F, Digre\u00a0K, Fraser\u00a0JA, Fraser\u00a0C et al (2018) Peripapillary hyperreflective ovoid mass-like structures: is it optic disc drusen or not?: response. J\u00a0Neuroophthalmol 38:568\u2013570","journal-title":"J Neuroophthalmol"},{"key":"1302_CR23","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/134858","author":"F Costello","year":"2013","unstructured":"Costello\u00a0F (2013) The afferent visual pathway: designing a\u00a0structural-functional paradigm of multiple sclerosis. ISRN Neurol. https:\/\/doi.org\/10.1155\/2013\/134858","journal-title":"ISRN Neurol"},{"issue":"7","key":"1302_CR24","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s00415-016-8127-y","volume":"263","author":"LJ Balk","year":"2016","unstructured":"Balk\u00a0LJ, Cruz-Herranz\u00a0A, Albrecht\u00a0P, Arnow\u00a0S, Gelfand\u00a0JM, Tewarie\u00a0P et al (2016) Timing of retinal neuronal and axonal loss in MS: a\u00a0longitudinal OCT study. J\u00a0Neurol 263(7):1323\u20131331","journal-title":"J Neurol"},{"issue":"5","key":"1302_CR25","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.ophtha.2017.01.005","volume":"124","author":"E Garcia-Martin","year":"2017","unstructured":"Garcia-Martin\u00a0E, Ara\u00a0JR, Martin\u00a0J, Almarcegui\u00a0C, Dolz\u00a0I, Vilades\u00a0E et al (2017) Retinal and optic nerve degeneration in patients with multiple sclerosis followed up for 5 years. Ophthalmology 124(5):688\u2013696","journal-title":"Ophthalmology"},{"issue":"2","key":"1302_CR26","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ophtha.2005.10.040","volume":"113","author":"JB Fisher","year":"2006","unstructured":"Fisher\u00a0JB, Jacobs\u00a0DA, Markowitz\u00a0CE, Galetta\u00a0SL, Volpe\u00a0NJ, Nano-Schiavi\u00a0ML et al (2006) Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology 113(2):324\u2013332","journal-title":"Ophthalmology"},{"issue":"2","key":"1302_CR27","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1097\/WNO.0000000000000662","volume":"38","author":"RC Nolan","year":"2018","unstructured":"Nolan\u00a0RC, Akhand\u00a0O, Rizzo\u00a0J\u2011R, Galetta\u00a0SL, Balcer\u00a0LJ (2018) Evolution of visual outcomes in clinical trials for multiple sclerosis disease-modifying therapies. J\u00a0Neuroophthalmol 38(2):202\u2013209","journal-title":"J Neuroophthalmol"},{"key":"1302_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2147\/EB.S139417","volume":"10","author":"F Costello","year":"2018","unstructured":"Costello\u00a0F, Burton\u00a0JM (2018) Retinal imaging with optical coherence tomography: a\u00a0biomarker in multiple sclerosis? Eye Brain 10:47\u201363","journal-title":"Eye Brain"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-022-01302-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00115-022-01302-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-022-01302-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T14:06:05Z","timestamp":1655301965000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00115-022-01302-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,25]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["1302"],"URL":"https:\/\/doi.org\/10.1007\/s00115-022-01302-5","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,25]]},"assertion":[{"value":"27 April 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>M.\u00a0Schultheiss<\/b>: A.\u00a0Finanzielle Interessen: Dr.-Karl-Robert-Brauns-Forschungspreis f\u00fcr Augenheilkunde - Forschungsprojekt gebundene Gelder (40.000 Euro).\u00a0\u2013 Referentent\u00e4tigkeit f\u00fcr Bayer und Novartis, hierbei wurden Reise- und \u00dcbernachtungskosten erstattet, sowie ein \u00fcbliches Honorar f\u00fcr die Referentent\u00e4tigkeit gezahlt.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellter Augenarzt am Universit\u00e4tsklinikum Hamburg-Eppendorf. <b>D.\u00a0Wenzel<\/b>: A.\u00a0Finanzielle Interessen: D. Wenzel gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellter Arzt in Weiterbildung, Universit\u00e4ts-Augenklinik, Universit\u00e4tsklinikum T\u00fcbingen\u00a0| Mitgliedschaft: Deutsche Ophthalmologische Gesellschaft. <b>M.\u00a0Spitzer<\/b>: A.\u00a0Finanzielle Interessen: BMBF, Forschungsf\u00f6rderung (Personal).\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Professor f\u00fcr Augenheilkunde und Klinikdirektor, Klinik und Poliklinik f\u00fcr Augenheilkunde\u00a0| Universit\u00e4tsklinikum Hamburg-Eppendorf (UKE), Martinistr. 52, 20251 Hamburg. <b>S.\u00a0Poli<\/b>: A.\u00a0Finanzielle Interessen: Forschungsf\u00f6rderung zur pers\u00f6nlichen Verf\u00fcgung: S.\u00a0Poli received research support from BMS\/Pfizer (ATTICUS trial, 2.2 Mio EUR), Boehringer-Ingelheim (REVISION trial, non-financial), Daiichi Sankyo (SPOCT-DOAC 1 study, 40,000 EUR), European Union (PROOF trial, 5.9 Mio EUR), German Federal Joint Committee Innovation Fund (APICES trial, 1.2 Mio EUR), and German Federal Ministry of Education and Research (REVISION trial 4.2 Mio EUR), Helena Laboratories (SPOCT-DOAC 1 study, non-financial), and Werfen (POCT-DOAC studies, non-financial).\u00a0\u2013 Referentenhonorar oder Kostenerstattung als passiver Teilnehmer: Speakers\u2019 honoraria\/consulting fees from Alexion, AstraZeneca, Bayer, Boehringer-Ingelheim, BMS\/Pfizer, Daiichi Sankyo, Portola, and Werfen (all non-significant and outside the submitted work).\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellter Neurologe, Zentrum f\u00fcr Neurologie, Abt. Neurologie mit Schwerpunkt neurovaskul\u00e4re Erkrankungen, Universit\u00e4tsklinikum T\u00fcbingen\u00a0| Mitgliedschaften: FESO, FAHA, FWSO, DGN, DGKN, DEGUM, GT\u00dcM. <b>H.\u00a0Wilhelm<\/b>: A.\u00a0Finanzielle Interessen: Bezahlter Berater\/interner Schulungsreferent\/Gehaltsempf\u00e4nger o.\u00e4.: Firma Chiesi: Inhaltliche Gestaltung eines Web-Inhalts zur Information f\u00fcr \u00c4rzte; Vortragshonorare und Reisekosten direkt oder durch Sponsoring von Th\u00e9a, Bayer und Santhera f\u00fcr Vortr\u00e4ge aus dem Bereich Neuroophthalmologie.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellter Arzt Universit\u00e4ts-Augenklinik T\u00fcbingen\u00a0| Mitgliedschaften: DOG, BVA, DMKG. <b>F.\u00a0Tonagel<\/b>: A.\u00a0Finanzielle Interessen: F. Tonagel gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellter Arzt an der Universit\u00e4tsaugenklinik T\u00fcbingen. <b>C.\u00a0Kelbsch<\/b>: A.\u00a0Finanzielle Interessen: Forschungsf\u00f6rderung zur pers\u00f6nlichen Verf\u00fcgung: Egon Schumacher-Stiftung, private Stiftung ohne kommerzielle Interessen.\u00a0\u2013 Honorar als Referent \u201eNeuroophthalmologie f\u00fcr Neurologen\u201c, Dessau, 05\/2018 (Firma Santhera).\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Funktionsober\u00e4rztin in der Abteilung f\u00fcr Neuroophthalmologie, Universit\u00e4ts-Augenklinik T\u00fcbingen\u00a0| Mitgliedschaft: DOG.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}